Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4QAW5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.470 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.664 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.474 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.720 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.689 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 256 | 258 | PF00082 | 0.720 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.689 |
CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.609 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.466 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.685 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.699 |
DOC_MAPK_gen_1 | 33 | 42 | PF00069 | 0.731 |
DOC_PP1_RVXF_1 | 273 | 280 | PF00149 | 0.445 |
DOC_PP4_FxxP_1 | 245 | 248 | PF00568 | 0.538 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.603 |
LIG_14-3-3_CanoR_1 | 116 | 121 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 239 | 249 | PF00244 | 0.732 |
LIG_14-3-3_CanoR_1 | 257 | 262 | PF00244 | 0.743 |
LIG_14-3-3_CanoR_1 | 64 | 72 | PF00244 | 0.570 |
LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.604 |
LIG_AP2alpha_2 | 120 | 122 | PF02296 | 0.631 |
LIG_BRCT_BRCA1_1 | 107 | 111 | PF00533 | 0.570 |
LIG_BRCT_BRCA1_1 | 118 | 122 | PF00533 | 0.475 |
LIG_FHA_2 | 179 | 185 | PF00498 | 0.456 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.602 |
LIG_LIR_Apic_2 | 117 | 121 | PF02991 | 0.557 |
LIG_LIR_Apic_2 | 243 | 248 | PF02991 | 0.535 |
LIG_LIR_Gen_1 | 276 | 286 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 276 | 282 | PF02991 | 0.565 |
LIG_Pex14_1 | 118 | 122 | PF04695 | 0.555 |
LIG_SH2_NCK_1 | 142 | 146 | PF00017 | 0.419 |
LIG_SH2_SRC | 142 | 145 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.545 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.678 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.484 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.510 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.595 |
LIG_SUMO_SIM_par_1 | 38 | 44 | PF11976 | 0.518 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.571 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.484 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.703 |
MOD_CK1_1 | 91 | 97 | PF00069 | 0.490 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.526 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.453 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.594 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.635 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.548 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.662 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.510 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.556 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.585 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.481 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.579 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.640 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.591 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.583 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.584 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.550 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.482 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.451 |
MOD_N-GLC_1 | 197 | 202 | PF02516 | 0.417 |
MOD_N-GLC_1 | 263 | 268 | PF02516 | 0.621 |
MOD_N-GLC_1 | 97 | 102 | PF02516 | 0.522 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.595 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.665 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.563 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.459 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.490 |
MOD_PKA_1 | 256 | 262 | PF00069 | 0.701 |
MOD_PKA_1 | 60 | 66 | PF00069 | 0.500 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.570 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.738 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.626 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.566 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.538 |
MOD_Plk_1 | 197 | 203 | PF00069 | 0.392 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.611 |
MOD_Plk_4 | 281 | 287 | PF00069 | 0.631 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.521 |
MOD_SUMO_for_1 | 277 | 280 | PF00179 | 0.532 |
TRG_DiLeu_BaEn_1 | 187 | 192 | PF01217 | 0.498 |
TRG_ER_diArg_1 | 33 | 35 | PF00400 | 0.643 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA94 | Leptomonas seymouri | 59% | 100% |
A0A0S4J4T0 | Bodo saltans | 33% | 97% |
A0A1X0NIP3 | Trypanosomatidae | 42% | 100% |
A0A3S7WY29 | Leishmania donovani | 93% | 100% |
A0A422P481 | Trypanosoma rangeli | 44% | 100% |
A4HD73 | Leishmania braziliensis | 81% | 100% |
D0A6Y5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AH27 | Leishmania infantum | 93% | 100% |
E9AWK5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5DSP6 | Trypanosoma cruzi | 42% | 100% |